The role of the microbiome in exacerbations of chronic lung diseases

The Lancet

Volumn 384, Issue 9944, 2014, Pages 691-702

  Dickson, Robert P ^a   Martinez, Fernando J ^b   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BACTERIAL DNA; RNA 16S;

AIR POLLUTION; AIRWAY OBSTRUCTION; ASTHMA; BACTERIAL LOAD; BACTERIUM IDENTIFICATION; BRONCHIECTASIS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DNA SEQUENCE; EXERCISE; FIBROSING ALVEOLITIS; GENERAL CONDITION DETERIORATION; HIGH THROUGHPUT SEQUENCING; HUMAN; LUNG LAVAGE; MICROBIAL COMMUNITY; MICROBIOME; NON CYSTIC BRONCHIECTASIS; NUTRIENT AVAILABILITY; PRIORITY JOURNAL; REVIEW; VIRAL RESPIRATORY TRACT INFECTION; ARTICLE; BACTERIOSTASIS; CULTURE TECHNIQUE; DYSBIOSIS; IMMUNE RESPONSE; LUNG FIBROSIS; MICROBIAL DIVERSITY; MUCOCILIARY CLEARANCE; PHENOTYPE; TOPOGRAPHY;

BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; CHRONIC DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG DISEASES; MICROBIOTA; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 84906673705     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)61136-3     Document Type: Review

References (138)

1. SA Strassels, DH Smith, SD Sullivan, PS Mahajan The costs of treating COPD in the United States Chest 119 2001 344 352
2. DH Smith, DC Malone, KA Lawson, LJ Okamoto, C Battista, WB Saunders A national estimate of the economic costs of asthma Am J Respir Crit Care Med 156 1997 787 793
3. TA Lieu, GT Ray, G Farmer, GF Shay The cost of medical care for patients with cystic fibrosis in a health maintenance organization Pediatrics 103 1999 e72
4. TA Seemungal, GC Donaldson, A Bhowmik, DJ Jeffries, JA Wedzicha Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 161 2000 1608 1613
5. GC Donaldson, TA Seemungal, A Bhowmik, JA Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852
6. TG Liou, FR Adler, SC Fitzsimmons, BC Cahill, JR Hibbs, BC Marshall Predictive 5-year survivorship model of cystic fibrosis Am J Epidemiol 153 2001 345 352
7. R Hyzy, S Huang, J Myers, K Flaherty, F Martinez Acute exacerbation of idiopathic pulmonary fibrosis Chest 132 2007 1652 1658
8. JV Hirschmann Do bacteria cause exacerbations of COPD? Chest 118 2000 193 203
9. ER Sutherland, RJ Martin Asthma and atypical bacterial infection Chest 132 2007 1962 1966
10. RP Dickson, JR Erb-Downward, GB Huffnagle The role of the bacterial microbiome in lung disease Expert Rev Respir Med 7 2013 245 257
11. M Chan-Yeung, JH Chang, J Manfreda, A Ferguson, A Becker Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma Am J Respir Crit Care Med 154 1996 889 893
12. R Magadle, N Berar-Yanay, P Weiner The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea Chest 121 2002 329 333
13. DB Sanders, LR Hoffman, J Emerson et al. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis Pediatr Pulmonol 45 2010 127 134
14. M Hamady, R Knight Microbial community profiling for human microbiome projects: tools, techniques, and challenges Genome Res 19 2009 1141 1152
15. XC Morgan, C Huttenhower Chapter 12: Human microbiome analysis PLoS Comput Biol 8 2012 e1002808
16. RP Dickson, JR Erb-Downward, CM Freeman et al. Changes in the lung microbiome following lung transplantation include the emergence of two distinct pseudomonas species with distinct clinical associations PLoS One 9 2014 e97214
17. A Suau, R Bonnet, M Sutren et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut Appl Environ Microbiol 65 1999 4799 4807
18. ES Charlson, K Bittinger, AR Haas et al. Topographical continuity of bacterial populations in the healthy human respiratory tract Am J Respir Crit Care Med 184 2011 957 963
19. MM Tunney, GG Einarsson, L Wei et al. Lung microbiota and bacterial abundance in paitents bronchiectasis when clinically stable and during exacerbation Am J Respir Crit Care Med 187 2013 1118 1126
20. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 486 2012 207 214
21. GB Rogers, CJ van der Gast, L Cuthbertson et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition Thorax 68 2013 731 737
22. YJ Huang, CE Nelson, EL Brodie et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma J Allergy Clin Immunol 127 2011 372 381 e1-3.
23. AA Pragman, HB Kim, CS Reilly, C Wendt, RE Isaacson The lung microbiome in moderate and severe chronic obstructive pulmonary disease PLoS One 7 2012 e47305
24. MK Han, Y Zhou, S Murray et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study Lancet Respir Med 2 2014 548 556
25. E Goleva, LP Jackson, JK Harris et al. The effects of airway microbiome on corticosteroid responsiveness in asthma Am J Respir Crit Care Med 188 2013 1193 1201
26. LN Segal, AV Alekseyenko, JC Clemente et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation Microbiome 1 2013 19
27. AF Goddard, BJ Staudinger, SE Dowd et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota Proc Natl Acad Sci USA 109 2012 13769 13774
28. MJ Cox, M Allgaier, B Taylor et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients PLoS One 5 2010 e11044
29. J Zhao, PD Schloss, LM Kalikin et al. Decade-long bacterial community dynamics in cystic fibrosis airways Proc Natl Acad Sci USA 109 2012 5809 5814
30. PL Molyneaux, P Mallia, MJ Cox et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 188 2013 1224 1231
31. J Zhao, S Murray, JJ Lipuma Modeling the impact of antibiotic exposure on human microbiota Sci Rep 4 2014 4345
32. Baas Becking LGM. Geobiology or introduction to the science of the environment: with bibliography and index: Van Stockum; 1934 (in German).
33. PS Hasleton The internal surface area of the adult human lung J Anat 112 1972 391 400
34. DS Dock, WL Kraus, GL Mc, JW Hyland, FW Haynes, L Dexter The pulmonary blood volume in man J Clin Invest 40 1961 317 328
35. HF Helander, L Fandriks Surface area of the digestive tract - revisited Scand J Gastroenterol 49 2014 681 689
36. RP Dickson, JR Erb-Downward, GB Huffnagle Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis Lancet Respir Med 2 2014 238 246
37. A Morris, JM Beck, PD Schloss et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers Am J Respir Crit Care Med 187 2013 1067 1075
38. B Lighthart Mini-review of the concentration variations found in the alfresco atmospheric bacterial populations Aerobiologia 16 2000 7 16
39. K Gleeson, DF Eggli, SL Maxwell Quantitative aspiration during sleep in normal subjects Chest 111 1997 1266 1272
40. EJ Huxley, J Viroslav, WR Gray, AK Pierce Pharyngeal aspiration in normal adults and patients with depressed consciousness Am J Med 64 1978 564 568
41. RM Bowers, AP Sullivan, EK Costello, JL Collett Jr, R Knight, N Fierer Sources of bacteria in outdoor air across cities in the midwestern United States Appl Environ Microbiol 77 2011 6350 6356
42. V Bertolini, I Gandolfi, R Ambrosini et al. Temporal variability and effect of environmental variables on airborne bacterial communities in an urban area of Northern Italy Appl Microbiol Biotechnol 97 2013 6561 6570
43. P Munyard, A Bush How much coughing is normal? Arch Dis Child 74 1996 531 534
44. JB West Regional differences in the lung Chest 74 1978 426 437
45. EP Ingenito, J Solway, ER McFadden Jr et al. Indirect assessment of mucosal surface temperatures in the airways: theory and tests J Appl Physiol 63 1987 2075 2083
46. TF Hatch Distribution and deposition of inhaled particles in respiratory tract Bacteriol Rev 25 1961 237 240
47. H Wu, A Kuzmenko, S Wan et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability J Clin Invest 111 2003 1589 1602
48. HO Coxson, JC Hogg, JR Mayo et al. Quantification of idiopathic pulmonary fibrosis using computed tomography and histology Am J Respir Crit Care Med 155 1997 1649 1656
49. HO Coxson, RM Rogers, KP Whittall et al. A quantification of the lung surface area in emphysema using computed tomography Am J Respir Crit Care Med 159 1999 851 856
50. F D'Ovidio, LG Singer, D Hadjiliadis et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant Ann Thorac Surg 80 2005 1254 1260
51. G Raghu, TD Freudenberger, S Yang et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis Eur Respir J 27 2006 136 142
52. D Worlitzsch, R Tarran, M Ulrich et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients J Clin Invest 109 2002 317 325
53. A Schmidt, A Belaaouaj, R Bissinger et al. Neutrophil elastase-mediated increase in airway temperature during inflammation J Cyst Fibros 2014 10.1016/j.jcf.2014.03.004 published online April 5.
54. MW Konstan, KA Hilliard, TM Norvell, M Berger Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation Am J Respir Crit Care Med 150 1994 448 454
55. N Soler, S Ewig, A Torres, X Filella, J Gonzalez, A Zaubet Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease Eur Respir J 14 1999 1015 1022
56. R Zalacain, V Sobradillo, J Amilibia et al. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease Eur Respir J 13 1999 343 348
57. Cystic Fibrosis Foundation Patient Registry Report http://www.cff.org/ UploadedFiles/research/ClinicalResearch/PatientRegistryReport/ 2012-CFF-Patient-Registry.pdf 2012 (accessed April 25, 2014).
58. SA Evans, SM Turner, BJ Bosch, CC Hardy, MA Woodhead Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa Eur Respir J 9 1996 1601 1604
59. ER McFadden Jr, BM Pichurko Intraairway thermal profiles during exercise and hyperventilation in normal man J Clin Invest 76 1985 1007 1010
60. A Papi, CM Bellettato, F Braccioni et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations Am J Respir Crit Care Med 173 2006 1114 1121
61. S Kanangat, GU Meduri, EA Tolley et al. Effects of cytokines and endotoxin on the intracellular growth of bacteria Infect Immun 67 1999 2834 2840
62. SK Kaza, S McClean, M Callaghan IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria Int J Med Microbiol 301 2011 26 33
63. R Porat, BD Clark, SM Wolff, CA Dinarello Enhancement of growth of virulent strains of Escherichia coli by interleukin-1 Science 254 1991 430 432
64. PP Freestone, RA Hirst, SM Sandrini et al. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia? Chest 142 2012 1200 1210
65. LR Marks, BA Davidson, PR Knight, AP Hakansson Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease mBio 4 2013 e00438 e00413
66. EA Van de Graaf, TA Out, CM Roos, HM Jansen Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids Am Rev Respir Dis 143 1991 362 368
67. AM Sass, C Schmerk, K Agnoli et al. The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia ISME J 7 2013 1568 1581
68. JA Wedzicha, TA Seemungal COPD exacerbations: defining their cause and prevention Lancet 370 2007 786 796
69. JR Hurst, J Vestbo, A Anzueto et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 2010 1128 1138
70. WR Perera, JR Hurst, TM Wilkinson et al. Inflammatory changes, recovery and recurrence at COPD exacerbation Eur Respir J 29 2007 527 534
71. DE O'Donnell, CM Parker COPD exacerbations. 3: Pathophysiology Thorax 61 2006 354 361
72. G Rohde, A Wiethege, I Borg et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study Thorax 58 2003 37 42
73. T Seemungal, R Harper-Owen, A Bhowmik et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 1618 1623
74. P Mallia, SD Message, V Gielen et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation Am J Respir Crit Care Med 183 2011 734 742
75. TM Wilkinson, JR Hurst, WR Perera, M Wilks, GC Donaldson, JA Wedzicha Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD Chest 129 2006 317 324
76. E Monso, J Ruiz, A Rosell et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush Am J Respir Crit Care Med 152 1995 1316 1320
77. S Sethi, N Evans, BJ Grant, TF Murphy New strains of bacteria and exacerbations of chronic obstructive pulmonary disease N Engl J Med 347 2002 465 471
78. S Sethi, R Sethi, K Eschberger et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 2007 356 361
79. DJ Vollenweider, H Jarrett, CA Steurer-Stey, J Garcia-Aymerich, MA Puhan Antibiotics for exacerbations of chronic obstructive pulmonary disease Cochrane Database Syst Rev 12 2012 CD010257.
80. RK Albert, J Connett, WC Bailey et al. Azithromycin for prevention of exacerbations of COPD N Engl J Med 365 2011 689 698
81. YJ Huang, S Sethi, T Murphy, S Nariya, HA Boushey, SV Lynch Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease J Clin Microbiol 52 2014 2813 2823
82. L Millares, R Ferrari, M Gallego et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa Eur J Clin Microbiol Infect Dis 33 2014 1101 1111
83. V Krishnan, GB Diette, CS Rand et al. Mortality in patients hospitalized for asthma exacerbations in the United States Am J Respir Crit Care Med 174 2006 633 638
84. RH Dougherty, JV Fahy Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype Clin Exp Allergy 39 2009 193 202
85. WW Busse, RF Lemanske Jr, JE Gern Role of viral respiratory infections in asthma and asthma exacerbations Lancet 376 2010 826 834
86. RF Lemanske Jr, EC Dick, CA Swenson, RF Vrtis, WW Busse Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions J Clin Invest 83 1989 1 10
87. V Graham, T Lasserson, BH Rowe Antibiotics for acute asthma Cochrane Database Syst Rev 3 2001 CD002741.
88. M Hilty, C Burke, H Pedro et al. Disordered microbial communities in asthmatic airways PLoS One 5 2010 e8578
89. PR Marri, DA Stern, AL Wright, D Billheimer, FD Martinez Asthma-associated differences in microbial composition of induced sputum J Allergy Clin Immunol 131 2013 346 352
90. R Wientzen, CB Prestidge, RI Kramer, GH McCracken, JD Nelson Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy Am J Dis Child 134 1980 1134 1138
91. AC Hyatt, BE Chipps, KM Kumor, ED Mellits, PS Lietman, BJ Rosenstein A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis J Pediatr 99 1981 307 314
92. RH Simon Cystic fibrosis: Antibiotic therapy for lung disease In: UpToDate, Post TW (Ed) http://www.uptodate.com/contents/cystic-fibrosis- antibiotic-therapy-for-lung-disease March 2014 (accessed April 24 2014).
93. MN Hurley, AH Ariff, C Bertenshaw, J Bhatt, AR Smyth Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis J Cyst Fibros 11 2012 288 292
94. AL Smith, SB Fiel, N Mayer-Hamblett, B Ramsey, JL Burns Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis Chest 123 2003 1495 1502
95. R Gold, A Overmeyer, B Knie, PC Fleming, H Levison Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis Pediatr Infect Dis 4 1985 172 177
96. GB Rogers, CA Hart, JR Mason, M Hughes, MJ Walshaw, KD Bruce Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling J Clin Microbiol 41 2003 3548 3558
97. GB Rogers, MP Carroll, DJ Serisier et al. Bacterial activity in cystic fibrosis lung infections Respir Res 6 2005 49
98. CD Sibley, MD Parkins, HR Rabin, K Duan, JC Norgaard, MG Surette A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients Proc Natl Acad Sci USA 105 2008 15070 15075
99. SV Lynch, KD Bruce The cystic fibrosis airway microbiome Cold Spring Harb Perspect Med 3 2013 a009738
100. KE Price, TH Hampton, AH Gifford et al. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation Microbiome 1 2013 27
101. LA Carmody, J Zhao, PD Schloss et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation Ann Am Thorac Soc 10 2013 179 187
102. FA Stressmann, GB Rogers, P Marsh et al. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J Cyst Fibros 10 2011 357 365
103. S Iwai, D Huang, S Fong et al. The lung microbiome of ugandan hiv-infected pneumonia patients is compositionally and functionally distinct from that of san franciscan patients PLoS One 9 2014 e95726
104. C Wong, L Jayaram, N Karalus et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial Lancet 380 2012 660 667
105. GB Rogers, NM Zain, KD Bruce et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis Ann Am Thorac Soc 11 2014 496 503
106. H Maughan, KS Cunningham, PW Wang et al. Pulmonary bacterial communities in surgically resected noncystic fibrosis bronchiectasis lungs are similar to those in cystic fibrosis Pulm Med 2012 2012 746358
107. Y Kondoh, H Taniguchi, Y Kawabata, T Yokoi, K Suzuki, K Takagi Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases Chest 103 1993 1808 1812
108. V Ambrosini, A Cancellieri, M Chilosi et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series Eur Respir J 22 2003 821 826
109. AG Richter, RA Stockley, L Harper, DR Thickett Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis Thorax 64 2009 692 697
110. A Russell, M Cox, M Moffatt, W Cookson, T Maher, P Molyneaux The respiratory microbiome in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 185 2012 A5174 (abstr).
111. L Shulgina, AP Cahn, ER Chilvers et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial Thorax 68 2013 155 162
112. F Alvarez-Lerma Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group Intensive Care Med 22 1996 387 394
113. DC Angus, T van der Poll Severe sepsis and septic shock N Engl J Med 369 2013 2063
114. AW Walker, JD Sanderson, C Churcher et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease BMC Microbiol 11 2011 7
115. I Ordas, L Eckmann, M Talamini, DC Baumgart, WJ Sandborn Ulcerative colitis Lancet 380 2012 1606 1619
116. L Saiman, BC Marshall, N Mayer-Hamblett et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial JAMA 290 2003 1749 1756
117. K Fellermann, D Ludwig, M Stahl, T David-Walek, EF Stange Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506) Am J Gastroenterol 93 1998 1860 1866
118. BB Finlay, G McFadden Anti-immunology: evasion of the host immune system by bacterial and viral pathogens Cell 124 2006 767 782
119. TT Hansel, PJ Barnes New drugs for exacerbations of chronic obstructive pulmonary disease Lancet 374 2009 744 755
120. JJ Hoogerwerf, AF de Vos, P Bresser et al. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans Am J Respir Crit Care Med 178 2008 34 41
121. A Muir, G Soong, S Sokol et al. Toll-like receptors in normal and cystic fibrosis airway epithelial cells Am J Respir Cell Mol Biol 30 2004 777 783
122. A Casadevall, LA Pirofski The damage-response framework of microbial pathogenesis Nat Rev Microbiol 1 2003 17 24
123. CD Sibley, K Duan, C Fischer et al. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections PLoS Pathog 4 2008 e1000184
124. FL Short, SL Murdoch, RP Ryan Polybacterial human disease: the ills of social networking Trends Microbiol 2014 10.1016/S0966-842X(14)00116-4 published online June 14.
125. KB Twomey, OJ O'Connell, Y McCarthy et al. Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa ISME 6 2012 939 950
126. SM Bloom, VN Bijanki, GM Nava et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease Cell Host Microbe 9 2011 390 403
127. NP McNulty, T Yatsunenko, A Hsiao et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins Sci Transl Med 3 2011 106ra106
128. ES Gollwitzer, BJ Marsland Microbiota abnormalities in inflammatory airway diseases - potential for therapy Pharmacol Ther 141 2014 32 39
129. C Kelly, C Ward, CS Stenton, G Bird, DJ Hendrick, EH Walters Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness Thorax 43 1988 684 692
130. SA Levin Ecosystems and the biosphere as complex adaptive systems Ecosystems 1 1998 431 436
131. JH Holland Complex adaptive systems Daedalus 121 1992 17 30
132. SE Page Diversity and complexity 2010 Princeton University Press
133. G An, Q Mi, J Dutta-Moscato, Y Vodovotz Agent-based models in translational systems biology Wiley Interdiscip Rev Syst Biol Med 1 2009 159 171
134. JH Holland Studying complex adaptive systems J Systems Sci Complexity 19 2006 1 8
135. M Slater, DW Rivett, L Williams et al. The impact of azithromycin therapy on the airway microbiota in asthma Thorax 69 2013 673 674
136. E Bruzzese, V Raia, MI Spagnuolo et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study Clin Nutr 26 2007 322 328
137. B Weiss, Y Bujanover, Y Yahav, D Vilozni, E Fireman, O Efrati Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study Pediatr Pulmonol 45 2010 536 540
138. C Lozupone, A Cota-Gomez, BE Palmer et al. Widespread colonization of the lung by Tropheryma whipplei in HIV infection Am J Respir Crit Care Med 187 2013 1110 1117